Methods for the treatment of peri-menopausal syndrome
CA 2118093 A1 · Owner: Eli Lilly And Company · Inventors: Cullinan, George Joseph; Termine, John David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating peri-menopausal syndrome comprising administering to a human in need of treatment an effective amount of a compound having the formula (I), wherein R1 and R3 are independently hydrogen -CH3, , or , wherein Ar is, optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 13, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 13, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 13, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.